Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern.
Schultz BM, Melo-González F, Duarte LF, Gálvez NM, Pacheco GA, Soto JA, Berríos-Rojas RV, González LA, Moreno-Tapia D, Rivera-Pérez D, Ríos M, Vázquez Y, Hoppe-Elsholz G, Vallejos OP, Iturriaga C, Urzua M, Navarrete MS, Rojas Á, Fasce R, Fernández J, Mora J, Ramírez E, Gaete-Argel A, Acevedo M, Valiente-Echeverría F, Soto-Rifo R, Weiskopf D, Grifoni A, Sette A, Zeng G, Meng W; CoronaVac03CL Study Group; González-Aramundiz JV, González PA, Abarca K, Kalergis AM, Bueno SM. Schultz BM, et al. Among authors: fasce r. medRxiv [Preprint]. 2022 Feb 7:2021.11.16.21266350. doi: 10.1101/2021.11.16.21266350. medRxiv. 2022. Update in: mBio. 2022 Aug 30;13(4):e0142322. doi: 10.1128/mbio.01423-22 PMID: 35441179 Free PMC article. Updated. Preprint.
Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial.
Bueno SM, Abarca K, González PA, Gálvez NM, Soto JA, Duarte LF, Schultz BM, Pacheco GA, González LA, Vázquez Y, Ríos M, Melo-González F, Rivera-Pérez D, Iturriaga C, Urzúa M, Dominguez A, Andrade CA, Berrios RV, Canedo-Marroquín G, Covián C, Moreno-Tapia D, Saavedra F, Vallejos OP, Donato P, Espinoza P, Fuentes D, González M, Guzmán P, Muñoz-Venturelli P, Pérez CM, Potin M, Rojas A, Fasce R, Fernández J, Mora J, Ramírez E, Gaete-Argel A, Oyarzún-Arrau A, Valiente-Echeverría F, Soto-Rifo R, Weiskopf D, Sette A, Zeng G, Meng W, González-Aramundiz JV, Kalergis AM. Bueno SM, et al. Among authors: fasce r. medRxiv [Preprint]. 2021 Apr 1:2021.03.31.21254494. doi: 10.1101/2021.03.31.21254494. medRxiv. 2021. Update in: Clin Infect Dis. 2022 Aug 24;75(1):e792-e804. doi: 10.1093/cid/ciab823 PMID: 35441164 Free PMC article. Updated. Preprint.
Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents.
Rivera-Pérez D, Méndez C, Diethelm-Varela B, Melo-González F, Vázquez Y, Meng X, Xin Q, Fasce RA, Fernández J, Mora J, Ramirez E, Acevedo ML, Valiente-Echeverría F, Soto-Rifo R, Grifoni A, Weiskopf D, Sette A, Astudillo P, Le Corre N, Abarca K, Perret C, González PA, Soto JA, Bueno SM, Kalergis AM. Rivera-Pérez D, et al. Among authors: fasce ra. Front Immunol. 2024 May 15;15:1372193. doi: 10.3389/fimmu.2024.1372193. eCollection 2024. Front Immunol. 2024. PMID: 38812507 Free PMC article.
Cross-species transmission and PB2 mammalian adaptations of highly pathogenic avian influenza A/H5N1 viruses in Chile.
Pardo-Roa C, Nelson MI, Ariyama N, Aguayo C, Almonacid LI, Munoz G, Navarro C, Avila C, Ulloa M, Reyes R, Luppichini EF, Mathieu C, Vergara R, González Á, González CG, Araya H, Fernández J, Fasce R, Johow M, Medina RA, Neira V. Pardo-Roa C, et al. Among authors: fasce r. bioRxiv [Preprint]. 2023 Jun 30:2023.06.30.547205. doi: 10.1101/2023.06.30.547205. bioRxiv. 2023. PMID: 37786724 Free PMC article. Preprint.
Highly pathogenic avian influenza A(H5N1) virus of clade 2.3.4.4b isolated from a human case in Chile causes fatal disease and transmits between co-housed ferrets.
Pulit-Penaloza JA, Brock N, Belser JA, Sun X, Pappas C, Kieran TJ, Basu Thakur P, Zeng H, Cui D, Frederick J, Fasce R, Tumpey TM, Maines TR. Pulit-Penaloza JA, et al. Among authors: fasce r. Emerg Microbes Infect. 2024 Dec;13(1):2332667. doi: 10.1080/22221751.2024.2332667. Epub 2024 Jun 13. Emerg Microbes Infect. 2024. PMID: 38494746 Free PMC article.
Dispersion patterns of SARS-CoV-2 variants Gamma, Lambda and Mu in Latin America and the Caribbean.
Gräf T, Martinez AA, Bello G, Dellicour S, Lemey P, Colizza V, Mazzoli M, Poletto C, Cardoso VLO, da Silva AF; COVIGEN; Motta FC, Resende PC, Siqueira MM, Franco L, Gresh L, Gabastou JM, Rodriguez A, Vicari A, Aldighieri S, Mendez-Rico J, Leite JA. Gräf T, et al. Nat Commun. 2024 Feb 28;15(1):1837. doi: 10.1038/s41467-024-46143-9. Nat Commun. 2024. PMID: 38418815 Free PMC article.
The first case of human infection with H5N1 avian Influenza A virus in Chile.
Castillo A, Fasce R, Parra B, Andrade W, Covarrubias P, Hueche A, Campano C, Tambley C, Rojas M, Araya M, Hernández F, Bustos P, Fernández J. Castillo A, et al. Among authors: fasce r. J Travel Med. 2023 Sep 5;30(5):taad083. doi: 10.1093/jtm/taad083. J Travel Med. 2023. PMID: 37310882 Free PMC article.
End-of-season influenza vaccine effectiveness during the Southern Hemisphere 2022 influenza season - Chile, Paraguay, and Uruguay.
Chard AN, Nogareda F, Regan AK, Barraza MFO, Fasce RA, Vergara N, Avendaño M, Penayo E, Vázquez C, Von Horoch M, Michel F, Alfonso A, Mogdasy C, Chiparelli H, Goñi N, Alegretti M, Loayza S, Couto P, Rodriguez A, Salas D, Fowlkes AL, Azziz-Baumgartner E. Chard AN, et al. Among authors: fasce ra. Int J Infect Dis. 2023 Sep;134:39-44. doi: 10.1016/j.ijid.2023.05.015. Epub 2023 May 16. Int J Infect Dis. 2023. PMID: 37201863 Free PMC article.
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults.
Méndez C, Peñaloza HF, Schultz BM, Piña-Iturbe A, Ríos M, Moreno-Tapia D, Pereira-Sánchez P, Leighton D, Orellana C, Covarrubias C, Gálvez NMS, Soto JA, Duarte LF, Rivera-Pérez D, Vázquez Y, Cabrera A, Bustos S, Iturriaga C, Urzua M, Navarrete MS, Rojas Á, Fasce RA, Fernández J, Mora J, Ramírez E, Gaete-Argel A, Acevedo M, Valiente-Echeverría F, Soto-Rifo R, Weiskopf D, Grifoni A, Sette A, Zeng G, Meng W; CoronaVac03CL Study Group; González-Aramundiz JV, González PA, Abarca K, Melo-González F, Bueno SM, Kalergis AM. Méndez C, et al. Among authors: fasce ra. EBioMedicine. 2023 May;91:104563. doi: 10.1016/j.ebiom.2023.104563. Epub 2023 Apr 24. EBioMedicine. 2023. PMID: 37099842 Free PMC article.
Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019-2020.
Williams T, Jackson S, Barr I, Bi S, Bhiman J, Ellis J, von Gottberg A, Lindstrom S, Peret T, Rughooputh S, Viegas M, Hirve S, Zambon M, Zhang W; WHO RSV Surveillance Group; Dia N, Razanazatovo N, Al-Nabet ADMH, Abubakar A, Tivane A, Barakat A, Naguib A, Aziz A, Vicari A, Moen A, Govindakarnavar A, Hall A, Darmaa B, Nathalie B, Herring B, Caetano BC, Whittaker B, Baumeister E, Nakouné E, Guthrie E, Inbanathan F, Nair H, Campbell H, Kadjo HA, Oumzil H, Heraud JM, Mott JA, Namulondo J, Leite J, Nahapetyan K, Al Ariqi L, Gazo MHI, Chadha M, Pisareva M, Venter M, Siqueira MM, Lumandas M, Niang M, Albuaini M, Salman M, Oberste S, Srikantiah P, Tang P, Couto P, Smith P, Coyle PV, Dussart P, Nguyen PN, Okada PA, Wijesinghe PR, Samuel R, Brown R, Pebody R, Fasce R, Jha R, Lindstrom S, Gerber S, Potdar V, Dong X, Deng YM. Williams T, et al. Among authors: fasce r. Influenza Other Respir Viruses. 2023 Jan 18;17(1):e13073. doi: 10.1111/irv.13073. eCollection 2023 Jan. Influenza Other Respir Viruses. 2023. PMID: 36824313 Free PMC article.
83 results